Advertisement

Index by author

September 01, 1996; Volume 50,Issue 3

  1. Alvaro, J D

    1. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;

  2. Animati, F

    1. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;

  3. Arai, H

    1. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
      H Arai and J A Escobedo
      Molecular Pharmacology September 1996, 50 (3) 522-528;

  4. Arcamone, F

    1. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;

  5. Bamberger, U

    1. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
      Z Liu, F Lheureux, J F Pouliot, A Heckel, U Bamberger and E Georges
      Molecular Pharmacology September 1996, 50 (3) 482-492;

  6. Barak, D

    1. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
      H Grosfeld, D Barak, A Ordentlich, B Velan and A Shafferman
      Molecular Pharmacology September 1996, 50 (3) 639-649;

  7. Barber, R

    1. Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;

  8. Berger, A

    1. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
      A Berger, R Bittman, R R Schmidt and S Spiegel
      Molecular Pharmacology September 1996, 50 (3) 451-457;

  9. Bigioni, M

    1. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;

  10. Birnbaumer, M

    1. A fully active nonglycosylated V2 vasopressin receptor.
      G Innamorati, H Sadeghi and M Birnbaumer
      Molecular Pharmacology September 1996, 50 (3) 467-473;
« Previous (Pages : 1 2 3 4 5 6 ... 15) Next »
Back to top

In this issue

Advertisement